On the other hand, EDIL3 (EGFR-activating, proangiogenic integrin ligand) was previously identified in exosomes from invasive bladder cancer cell lines and from urine of patients with high-grade UBC [6]. This evidence concerns the gene EDIL3 and urinary bladder carcinoma.